Laser Treatment of Reticular Leg Veins Vs. Sclerotherapy

NCT06175754 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 174

Last updated 2025-02-05

No results posted yet for this study

Summary

Treatment of reticular veins with a 1064 nm long-pulsed Nd:YAG laser and combination of a 1064 nm Nd:YAG long pulse laser and sclerotherapy should be no less effective than sclerotherapy alone, and have a frequency of adverse events less then sclerotherapy alone.

Conditions

  • Reticular Leg Veins

Interventions

PROCEDURE

Laser ablation

Examination, photographing, inclusion in the study, signing of informed consent, randomization, diameter measurement, laser

PROCEDURE

Laser with Sclerotherapy

Examination, photographing, inclusion in the study, signing of informed consent, randomization, diameter measurement, laser plus sclerotherapy

PROCEDURE

Sclerotherapy

Examination, photographing, inclusion in the study, signing of informed consent, randomization, diameter measurement, sclerotherapy

Sponsors & Collaborators

  • Derzhavin Tambov State University

    lead OTHER

Principal Investigators

  • Oksana V Bukina, PhD · Derzhavin Tambov State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-09
Primary Completion
2025-07-09
Completion
2025-12-09

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06175754 on ClinicalTrials.gov